Search alternatives:
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
wt decrease » we decrease (Expand Search), _ decrease (Expand Search), nn decrease (Expand Search)
e decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
2241
-
2242
BC−/EC+ exhibited increased end-systolic and end-diastolic volume and decreased left ventricular function 3 weeks post MI.
Published 2015“…<p>BC−/EC+ exhibited an increase in end-systolic (<b>A</b>) and end-diastolic volume (<b>B</b>), a significantly more pronounced decrease in stroke volume (<b>C</b>) (BC+/EC+ n = 8 and BC−/EC+ n = 5; two-way ANOVA and Bonferroni’s post hoc test or student’s t-test; * p<0.05, ** p≤ 0.01 BC+/EC+ vs. …”
-
2243
-
2244
-
2245
-
2246
-
2247
-
2248
-
2249
Retinoschisin secretion into the conditioned medium is decreased by addition of jasplakinolide.
Published 2013“…As seen, retinoschisin secretion into the conditioned medium is decreased by 1 uM jasplakinolide. (C) Quantification of the intensity of each band in the Western blot in (B) (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0020707#s4" target="_blank">MATERIALS AND METHODS</a>). …”
-
2250
-
2251
-
2252
-
2253
-
2254
siRNA treatment decreases ADAMTS-1 nuclear pattern in MDA-MB-231 cells.
Published 2016“…(D-E) Aggrecan Western blot after digestion. Lane 1: Aggrecan from bovine articular cartilage (300 nM); Lane 2: Aggrecan from bovine articular cartilage (300 nM) incubated with 30 μg of MDA-MB-231 nuclear fraction; Lane 3: 30 μg of MDA-MB-231 nuclear fraction. …”
-
2255
A brief course of RAP treatment decreases markers of proliferation and increases markers of differentiation.
Published 2014“…<p><i>CDX2P-CreER<sup>T2</sup> Apc<sup>fl/fl</sup></i> mice were injected with TAM and monitored until polyposis was seen endoscopically, then the mice were treated with vehicle or RAP at 3 mg/kg concentration for periods of one, three, or five days (N = 5 per timepoint). …”
-
2256
-
2257
-
2258
Nilotinib decreases viability and proliferation of HEI-193 cells in a dose-dependent manner.
Published 2013“…Shown, mean value of six technical replicates. *denotes significant value (<i>p</i><0.05), **denotes significant value (p<0.005) (A) Nilotinib decreased absorbance on MTS viability assay in both growth conditions. …”
-
2259
-
2260